PTC Therapeutics Target Price

Where could PTCT trade next? Consensus target price: $110.

Get informed when a big investor buys or sells

+ Follow

Share Price

$63.46

Average Target Price

$111.38

75.5% upside

8 analysts in the last 4 months

High: $137 | Low: $85

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-22	Cantor FitzgeraldKristen Kluska	$137	115.9% upside
2026-09-14	Leerink Partners	$98	54.4% upside
2026-08-14	BarclaysEliana Merle	$122	92.2% upside
2026-08-13	Wells Fargo	$109	71.8% upside
2026-07-31	Morgan Stanley	$104	63.9% upside
2026-07-31	Wells Fargo	$106	67% upside
2026-07-16	Cantor Fitzgerald	$130	104.9% upside
2026-07-07	RBC Capital	$85	33.9% upside
2026-05-27	Jefferies	$85	33.9% upside
2026-05-08	Morgan StanleyJudah Frommer	$94	48.1% upside
2026-04-10	Raymond JamesTiago Fauth	$108	70.2% upside
2026-02-23	Morgan Stanley	$92	45% upside
2026-02-23	BarclaysEliana Merle	$120	89.1% upside
2026-02-20	RBC CapitalBrian Abrahams	$82	29.2% upside
2026-02-20	Wells Fargo	$86	35.5% upside
2026-01-27	Barclays	$119	87.5% upside
2026-01-08	Morgan Stanley	$90	41.8% upside
2025-12-01	RBC Capital	$91	43.4% upside
2025-11-05	Goldman Sachs	$50	21.2% downside
2025-11-05	Wells FargoTiago Fauth	$93	46.5% upside
2025-11-05	BarclaysGena Wang	$68	7.2% upside
2025-10-28	JefferiesKelly Shi	$77	21.3% upside
2025-08-08	Robert W. BairdJoel Beatty	$70	10.3% upside
2025-05-07	Robert W. BairdJoel Beatty	$66	4% upside
2025-01-07	RBC CapitalBrian Abrahams	$58	8.6% downside
2024-11-27	Robert W. BairdJoel Beatty	$52	18.1% downside
2024-10-11	Morgan StanleyJeffrey Hung	$45	29.1% downside
2024-08-26	UBSColin Bristow	$47	25.9% downside
2024-07-12	Morgan StanleyJeffrey Hung	$32	49.6% downside
2024-05-20	Goldman SachsPaul Choi	$32	49.6% downside
2024-05-20	JefferiesKelly Shi	$46	27.5% downside
2024-04-26	Morgan StanleyJeffrey Hung	$30	52.7% downside
2022-12-14	Goldman Sachs	$35	44.8% downside
2022-06-23	RBC CapitalBrian Abrahams	$46	27.5% downside
2022-04-05	Cantor FitzgeraldKristen Kluska	$63	0.7% downside
2021-08-31	UBSColin Bristow	$45	29.1% downside

PTC Therapeutics (PTCT) FAQ

PTC Therapeutics's target price stands at $110. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $110 for PTCT implies 75.5% upside versus today's price ($63.46). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how PTC Therapeutics's target price evolved across reporting periods, while the comparison chart places PTCT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. PTC Therapeutics's reading of $110 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.